MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

09 Feb 2024 Evaluate
A fair growth of 19.81% in the revenue at Rs. 1169.94 millions was reported in the December 2023 quarter as compared to Rs. 976.46 millions during year-ago period.Net profit surges 62.93% to Rs. 174.51  millions  from Rs. 107.11 millions in the quarter ended December 2023.Operating profit surged to 253.38 millions from the corresponding previous quarter of 158.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1169.94 976.46 19.81 2941.69 2793.19 5.32 3796.36 4058.42 -6.46
Other Income 37.64 36.78 2.34 113.98 97.22 17.24 145.42 153.83 -5.47
PBIDT 253.38 158.34 60.02 469.72 411.37 14.18 589.34 948.56 -37.87
Interest 0.54 0.16 237.50 1.08 0.60 80.00 0.77 4.85 -84.12
PBDT 252.84 158.18 59.84 468.64 410.77 14.09 588.57 943.71 -37.63
Depreciation 15.76 13.14 19.94 45.22 39.02 15.89 52.12 37.95 37.34
PBT 237.08 145.04 63.46 423.42 371.75 13.90 536.45 905.76 -40.77
TAX 62.57 37.93 64.96 110.28 100.36 9.88 138.11 233.88 -40.95
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 174.51 107.11 62.93 313.14 271.39 15.38 398.34 671.88 -40.71
Equity 28.91 29.23 -1.09 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 21.66 16.22 33.56 15.97 14.73 8.42 15.52 23.37 -33.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..